Lead Product(s): Dronabinol
Therapeutic Area: Gastroenterology Product Name: Reduvo Adversa
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: DanCann Pharma
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement May 05, 2021
DanCann Pharma will exclusively distribute Tetra Bio's Reduvo™ Adversa®, QIXLEEF™ and ENJOUCA™ in Denmark, Norway, Sweden, Finland, and Germany.